These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11132381)

  • 21. Conventional parasitology and DNA-based diagnostic methods for onchocerciasis elimination programmes.
    Lloyd MM; Gilbert R; Taha NT; Weil GJ; Meite A; Kouakou IM; Fischer PU
    Acta Trop; 2015 Jun; 146():114-8. PubMed ID: 25818324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of onchocerciasis: a controlled clinical trial of topical diethylcarbamazine (DEC) in Guatemala.
    Taylor HR; Langham ME; de Stahl EM; Figueroa LN; Beltranena F
    Tropenmed Parasitol; 1980 Sep; 31(3):357-64. PubMed ID: 7003855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
    Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Human onchocerciasis in Africa].
    Boussinesq M
    Med Trop (Mars); 1997; 57(4):389-400. PubMed ID: 9612783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of moderate urine alkalinisation on low dose diethylcarbamazine therapy in patients with onchocerciasis.
    Awadzi K; Adjepon-Yamoah KK; Edwards G; Orme ML; Breckenridge AM; Gilles HM
    Br J Clin Pharmacol; 1986 Jun; 21(6):669-76. PubMed ID: 3017392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of a topical Mazzotti test in the diagnosis of onchocerciasis.
    Kilian HD
    Trop Med Parasitol; 1988 Sep; 39(3):235-8. PubMed ID: 3194667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A transepidermal chemotherapy of onchocerciasis.
    Langham ME; Traub ZD; Richardson R
    Tropenmed Parasitol; 1978 Jun; 29(2):156-62. PubMed ID: 675836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
    Diallo S; Aziz MA; Lariviere M; Diallo JS; Diop-Mar I; N'Dir O; Badiane S; Py D; Schulz-Key H; Gaxotte P
    Trans R Soc Trop Med Hyg; 1986; 80(6):927-34. PubMed ID: 3299905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onchocerciasis in Canada.
    Seah SK
    Can Med Assoc J; 1974 Mar; 110(6):665-8. PubMed ID: 4817212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity.
    Lipner EM; Dembele N; Souleymane S; Alley WS; Prevots DR; Toe L; Boatin B; Weil GJ; Nutman TB
    J Infect Dis; 2006 Jul; 194(2):216-21. PubMed ID: 16779728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in controlling the reinvasion of windborne vectors into the western area of the Onchocerciasis Control Programme in West Africa.
    Baker RH; Guillet P; Sékétéli A; Poudiougo P; Boakye D; Wilson MD; Bissan Y
    Philos Trans R Soc Lond B Biol Sci; 1990 Jun; 328(1251):731-47, discussion 747-50. PubMed ID: 1976266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
    Dadzie KY; Bird AC; Awadzi K; Schulz-Key H; Gilles HM; Aziz MA
    Br J Ophthalmol; 1987 Feb; 71(2):78-85. PubMed ID: 3548811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mectizan and onchocerciasis: 10 years of Mectizan in Africa, a partnership for prolonged success].
    Pacqué M
    Sante; 1998; 8(1):77-8. PubMed ID: 9592889
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection.
    Lagatie O; Njumbe Ediage E; Batsa Debrah L; Diels L; Nolten C; Vinken P; Debrah A; Dillen L; Silber S; Stuyver LJ
    Parasit Vectors; 2016 May; 9(1):302. PubMed ID: 27216752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Onchocerca volvulus infection by O-150 polymerase chain reaction analysis of skin scratches.
    Toé L; Boatin BA; Adjami A; Back C; Merriweather A; Unnasch TR
    J Infect Dis; 1998 Jul; 178(1):282-5. PubMed ID: 9652456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onchocerciasis in West Africa after 2002: a challenge to take up.
    Hougard JM; Yameogo L; Philippon B
    Parasite; 2002 Jun; 9(2):105-11. PubMed ID: 12116855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.